Subcutaneous Drug Delivery Devices Market with Leading Players like Insulet Corporation, BD, Enable Injections Consort Medical Plc West Pharmaceutical Services, Inc. Elcam Medical, Amgen Ypsomed, AG SCPharmaceuticals, Inc. Wilhelm Haselmeier, GmbH & Co. K

This market research report provides a comprehensive picture on “Subcutaneous Drug Delivery Devices Market”, from the global viewpoint, offering a forecast and statistic in terms of revenue during the forecast period. The report covers a descriptive analysis with detailed segmentation, complete research and development history, latest news and press releases. Furthermore, the study explains the future opportunities and a sketch of key players operating in the “Subcutaneous Drug Delivery Devices Market”.

The global subcutaneous drug delivery devices market is expected to reach US$ 17,290.47 Mn in 2027 from US$ 9,243.80 in 2018. The market is estimated to grow with a CAGR of 7.4% from 2020-2027.

Get a sample copy of this report :-

https://www.theinsightpartners.com/sample/TIPRE00006411/?utm_source=OpenPR&utm_medium=10271

The increased number of chronic disease prevalence around the globe, significant number of vaccination and immunization programs that incorporate the use of subcutaneous drug delivery devices for therapeutic administration, rise in the research and development of new products leading to the subsequent introduction of novel solutions and devices in the market are expected to account for the growth of the market. However, risk of infections and other diseases associated with the use of injections and syringes is likely to hamper the market growth.

The key players influencing the market are:

Insulet Corporation
BD
Enable Injections
Consort Medical Plc
West Pharmaceutical Services, Inc.
Elcam Medical
Amgen
Ypsomed AG
SCPharmaceuticals, Inc.
Wilhelm Haselmeier GmbH & Co. KG

This report contains:

Market sizing for the Global Subcutaneous Drug Delivery Devices
Compare major Subcutaneous Drug Delivery Devices strategies and approaches to the challenges they face
Analysis of the effects deglobalisation trends may have for Subcutaneous Drug Delivery Devices
Profiles of major Subcutaneous Drug Delivery Devices providers
7-year CAGR forecasts for Subcutaneous Drug Delivery Devices -intensive vertical sectors

Strategic Insights

Some of the organic and inorganic growth activities are undertaken by the company, which have promoted the market growth. The companies have utilized strategies such as product launches, product approvals the growth of companies which is further expected to enhance the growth of the market during the coming years. For instance, in June 2018, Insulet received FDA 510(k) clearance for the Omnipod DASHTM Insulin Management System (Omnipod DASH). This clearance set up the foundation for a stable pace of innovation that enables Insulet to allow users to enjoy simplicity, healthier lives, and freedom swith their differentiated technology.

GLOBAL SUBCUTANEOUS DRUG DELIVERY DEVICES MARKET SEGMENTATION

Global Subcutaneous Drug Delivery Devices Market – By Technology

Syringes
Pens
Patches
Others
Global Subcutaneous Drug Delivery Devices Market – By Syringe Type

Prefilled Injectable
Filled Injectable
Global Subcutaneous Drug Delivery Devices Market – By Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Subcutaneous Drug Delivery Devices Market – By Region

North America
U.S.
Canada
Mexico
Europe
France
Germany
UK
Spain
Italy
Asia Pacific (APAC)
China
India
Japan
Australia
South Korea
Middle East & Africa (MEA)
Saudi Arabia
South Africa
UAE
South America (SAM)
Brazil
Argentina

Syringe Type Insights

The global subcutaneous drug delivery devices market, based on the syringe type was segmented into fillable injectable and prefilled injectable. In 2018, the fillable injectable held a largest market share of the subcutaneous drug delivery devices market, by syringe type. However, the prefilled injectable segment is expected to witness the highest CAGR over the coming years. The use of prefilled injectable devices such as syringes have expanded and overcame the traditional drug delivery approaches. Moreover, these syringes have been utilized across multiple therapeutic sectors including blood stimulants, vaccines, therapeutic protein, hormones, drugs, supplements, nutraceuticals and others.

For More Information On This Report, Please Visit:

https://www.theinsightpartners.com/buy/TIPRE00006411/?utm_source=OpenPR&utm_medium=10271

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Semiconductors, Healthcare, Manufacturing, Automotive and Defense.

This release was published on openPR.